News from EAS 2024: Anti-inflammatory effects GLP-1RA in T2D

Anti inflammatory effects of semaglutide in diabetes

Media formats available:

Ready to Claim Your Credits?

You have attempts to pass this post-test. Take your time and review carefully before submitting.

Good luck!

Recommended

Long-term efficacy and safety data of lomitapide in HoFH
Long-term efficacy and safety data of lomitapide in HoFH
EAS 2024
Long-term efficacy and safety data of lomitapide in HoFH
- Dirk Blom, PhD
Causal relationship between elevated Lp(a) levels and CKD risk
Causal relationship between elevated Lp(a) levels and CKD risk
EAS 2024
Causal relationship between elevated Lp(a) levels and CKD risk
- Anne Langsted, MD, PhD
LDL-c lowering with PCSK9 inhibitor in ASCVD patients without acute ischemic event
LDL-c lowering with PCSK9 inhibitor in ASCVD patients without acute ischemic event
EAS 2024
LDL-c lowering with PCSK9 inhibitor in ASCVD patients without acute ischemic event
- Pasquale Perrone-Filardi, MD, PhD
Bempedoic acid: effective tool in the toolkit for LDL-c lowering
Bempedoic acid: effective tool in the toolkit for LDL-c lowering
EAS 2024
Bempedoic acid: effective tool in the toolkit for LDL-c lowering
- Stephen Nicholls, FRACP, FACC, FESC, FAHA